To further investigate the influence of antihypertensive drugs on the risk of different histological types of kidney cancer, we performed two-sample MR to study the effect of genetically proxied therapeutic inhibition for antihypertensive drug targets on the risk of ccRCC, pRCC, and chRCC. This evidence concerns the gene PRCC and nonpapillary renal cell carcinoma.